Product
Travoprost
6 clinical trials
5 indications
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionIndication
Angle-closure GlaucomaIndication
Intraocular PressureClinical trial
Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite vs. iStent Infinite Alone in Subjects With Open-angle Glaucoma or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular ImplantStatus: Completed, Estimated PCD: 2022-02-28
Clinical trial
Multicenter, Randomized, Double-Masked, Active-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Travoprost Ophthalmic Topical Cream in Subjects With Open-angle Glaucoma or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Twelve-Week, Double Masked, Parallel Group, Primary-Therapy Pilot Study of the Safety and Efficacy of Travoprost 0.004% Compared to Pilocarpine 1% in Patients With Chronic Angle-Closure GlaucomaStatus: Completed, Estimated PCD: 2008-05-01
Clinical trial
A Double-Masked, Parallel-Group, Efficacy and Safety Study of Brinzolamide 1.0% (AZOPT) as Adjunctive Therapy to Travoprost 0.004% (TRAVATAN) in Patients With Chronic Angle-Closure GlaucomaStatus: Terminated, Estimated PCD: 2008-03-01
Clinical trial
Stop Retinal Ganglion Cell Dysfunction StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-01